Low vaccination rates for influenza viruses and the lack of an HSV vaccine underscore the need for a new approach to reduce viral transmission. Researchers have now used a clinical-grade antiviral ...
The following is a summary of “A viro-immunological model to characterize the antiviral effect of molnupiravir in SARS-CoV-2-infected outpatients: implication for treatment duration,” published in the ...
In the fight against bacterial pathogens, researchers are combining vaccination with targeted colonization of the intestine by harmless microorganisms. This approach could potentially mark a turning ...
Fusarium oxysporum is a soil-borne fungal pathogen that causes a group of serious plant diseases known as Fusarium wilts. As ...
G avi, the Vaccine Alliance, supplies vaccines to nearly half of the world’s children. For decades, governments, institutions ...
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...
Ensitrelvir PEP was safe and effective for COVID-19 prevention among household contacts when administered after the onset of symptoms in an index patient.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results